Back DiMarchi, R Efendic, S (1997) 'Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity', US Patent US6191102B1.Back Drucker, DJ, Habener, JF, Holst, JJ (1 Dec 2017) 'Discovery, characterization, and clinical development of the glucagon-like peptides', Journal of Clinical Investigation , 127/12, 4217-27
Many insurance plans cover GLP-1s for other FDA-approved conditions, even if they dont cover them for weight loss alone
Cons Compounded formulations are not the same as FDA-approved brand products, and long-term trial data are limited
Some researchers skip priming (drawing a small amount and pushing it back, or tapping out air bubbles thoroughly) and end up injecting mostly air for their first dose
Dispose of the needle in your sharps container